Literature DB >> 22462788

The proteomic toolbox for studying cerebrospinal fluid.

Alain J van Gool1, Ronald C Hendrickson.   

Abstract

Cerebrospinal fluid (CSF) can be considered the most promising biosample for the discovery and analysis of biomarkers in neuroscience, an area of great medical need. CSF is a body fluid that surrounds the brain and provides a rich pool of biochemical markers, both proteomic and metabolomic, that reflect the state of neurological processes. Such biomarkers can either serve as diagnostic or prognostic biomarkers to improve the characterization of patients and preclinical disease models, or can be used to demonstrate drug-related exposure and efficacy. Here, we describe the proteomic toolbox for studying CSF from a drug-discovery perspective, and the trends and challenges that lie ahead.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22462788     DOI: 10.1586/epr.12.6

Source DB:  PubMed          Journal:  Expert Rev Proteomics        ISSN: 1478-9450            Impact factor:   3.940


  3 in total

1.  Applying mass spectrometry-based qualitative proteomics to human amygdaloid complex.

Authors:  Joaquín Fernández-Irigoyen; María V Zelaya; Enrique Santamaría
Journal:  Front Cell Neurosci       Date:  2014-03-20       Impact factor: 5.505

Review 2.  Non-Invasive Nasal Discharge Fluid and Other Body Fluid Biomarkers in Alzheimer's Disease.

Authors:  Da Hae Jung; Gowoon Son; Oh-Hoon Kwon; Keun-A Chang; Cheil Moon
Journal:  Pharmaceutics       Date:  2022-07-22       Impact factor: 6.525

3.  Quantitative Proteomics of Cerebrospinal Fluid in Paediatric Pneumococcal Meningitis.

Authors:  Guadalupe Gómez-Baena; Richard J Bennett; Carmen Martínez-Rodríguez; Małgorzata Wnęk; Gavin Laing; Graeme Hickey; Lynn McLean; Robert J Beynon; Enitan D Carrol
Journal:  Sci Rep       Date:  2017-08-01       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.